$RGEN REPLIGEN CORP Insider Trading
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REPLIGEN CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in REPLIGEN CORP for free.
CIK Number: 0000730272
IRS Number: 042729386
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: RGEN
Company Address: 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM 02453
Phone number: 781-250-0111
Market Capitalization: $984.14M
Prev close: $29.24
Average Daily Volume: 237,135
Days Low: $28.88
Year Low: $21.07
Year High: $34.06
REPLIGEN CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | M | 86.10 | 1,045 | 89,975 | 2,092 | |
Jun 14 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | M | 59.52 | 2,557 | 152,193 | 1,354 | |
Jun 14 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 189.19 | 6,802 | 1,286,870 | 21,355 | 28.2 K to 21.4 K (-24.16 %) |
Jun 14 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Buy | M | 86.10 | 1,045 | 89,975 | 28,157 | 27.1 K to 28.2 K (+3.85 %) |
Jun 14 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Buy | M | 59.52 | 2,557 | 152,193 | 27,112 | 24.6 K to 27.1 K (+10.41 %) |
May 18 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 172.60 | 470 | 81,122 | 31,893 | 32.4 K to 31.9 K (-1.45 %) |
May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | M | 3.22 | 15,000 | 48,300 | 0 | |
May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 176.85 | 285 | 50,402 | 115,449 | 115.7 K to 115.4 K (-0.25 %) |
May 13 2021 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Buy | M | 3.22 | 15,000 | 48,300 | 115,734 | 100.7 K to 115.7 K (+14.89 %) |
Apr 08 2021 | RGEN | REPLIGEN CORP | Bylund James | SVP, Global Operati ... | Sell | S | 204.25 | 360 | 73,530 | 6,324 | 6.7 K to 6.3 K (-5.39 %) |
Mar 18 2021 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | Sell | S | 196.88 | 1,400 | 275,632 | 37,140 | 38.5 K to 37.1 K (-3.63 %) |
Mar 16 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 170 | 0 | 1,294 | 1.5 K to 1.3 K (-11.61 %) |
Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 194.08 | 235 | 45,609 | 212,762 | 213 K to 212.8 K (-0.11 %) |
Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 193.30 | 227 | 43,879 | 212,997 | 213.2 K to 213 K (-0.11 %) |
Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 192.17 | 1,378 | 264,810 | 213,224 | 214.6 K to 213.2 K (-0.64 %) |